什么时候和多长时间治疗慢性淋巴细胞白血病?
Carsten U Niemann1, Abraham Varghese2, Talha Munir2
1Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
概括
慢性淋巴细胞白血病 (CLL) 通常是无法治愈的. 目前的证据不支持对无症状高风险患者的早期治疗,维持观察和等待策略作为标准护理.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 慢性淋巴细胞白血病 (CLL) 是一种常见的B细胞恶性瘤,临床过程可变.
- 虽然全基性干细胞移植可以治愈,但它只适用于罕见病例.
- 目前的治疗决策依赖于分期系统 (Rai,Binet) 和疾病活动.
研究的目的:
- 评估早期干预在无症状高风险CLL患者的有效性.
- 评估新型向治疗在早期CLL中的作用.
- 确定CLL的最佳管理策略.
主要方法:
- 对慢性淋巴细胞白血病 (CLL) 管理的当前临床指南和试验数据的审查.
- 对早期CLL患者的生存结果的分析,这些患者接受了不同的治疗方法.
- 在无症状患者中评估布鲁顿的氨酸激酶和BCL2抑制剂的影响.
主要成果:
- 在无症状,高风险的CLL患者早期开始治疗并没有证明整体生存益处.
- 像布鲁顿的氨酸激酶和BCL2抑制剂这样的向疗法并没有改善这一群体的生存率.
- 观察和等待的策略仍然是对无症状的CLL的标准护理.
结论:
- 观察和等待方法是目前无症状慢性淋巴细胞白血病 (CLL) 的标准.
- 需要进一步的研究来确定可能受益于早期治疗的特定高危子组.
- 未来的临床试验可能会完善在特定的CLL患者中启动治疗的指示.
更多相关视频
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
10.9K
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
7.2K
相关概念视频
01:28Pulmonary Tuberculosis V
150
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
150
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K